)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Marker Therapeutics
Marker Therapeutics (MRKR) investor relations material
Marker Therapeutics Oppenheimer 36th Annual Healthcare Life Sciences Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Oppenheimer 36th Annual Healthcare Life Sciences Conference summary25 Feb, 2026
Technology overview and differentiation
MAR-T platform is a first-in-class, natural T-cell therapy that does not require genetic modification and targets multiple tumor antigens.
Demonstrates a favorable safety profile with no ICANS, HLH, or severe CRS observed in clinical studies.
Manufacturing process is straightforward, with a current vein-to-vein time of 22 days, aiming to reduce to 17 days.
Technology is licensed from Baylor College of Medicine, with global intellectual property rights.
Clinical data and efficacy
MT-601 shows a 66% overall response rate in non-Hodgkin lymphoma and 78% in Hodgkin lymphoma, including heavily pretreated patients.
Complete response rate in non-Hodgkin lymphoma is 50%, with durable responses observed beyond one year.
Responses are seen even at lower dose levels, with dose escalation up to 400 million cells well tolerated.
No dose-limiting toxicities or long-term adverse effects reported; only mild, manageable CRS.
Strategic focus and market opportunity
Priority is to advance MT-601 as a single-arm pivotal study for LBCL patients who failed CAR T-cell therapy.
LBCL post-CAR T-cell market could exceed $3 billion by 2030.
Expansion plans include solid tumors (pancreatic cancer) and an off-the-shelf AML program.
Government grants exceeding $30 million support clinical development and de-risk new programs.
Rationale for single-arm pivotal study in LBCL
How does MAR-T safety profile impact market access?
How do grants de-risk solid tumor/off-shelf programs
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Marker Therapeutics earnings date
Q4 202531 Mar, 2026
Marker Therapeutics
Next Marker Therapeutics earnings date
Q4 202531 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Marker Therapeutics Inc is a U.S.-based biotechnology company focused on the development of immunotherapies for cancer. The company’s therapeutic approach involves multi-tumor antigen-specific T cell therapies that are designed to target various hematological and solid tumors. It conducts clinical trials and research collaborations to advance its cell therapy platforms. It is headquartered in Houston, Texas, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage